These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34852078)

  • 21. Applying human rights to improve access to reproductive health services.
    Shaw D; Cook RJ
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S55-9. PubMed ID: 22883913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
    Srivastava D; McGuire A
    BMC Public Health; 2014 Jul; 14():767. PubMed ID: 25073407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: analysis of the effect of TRIPs-Plus proposal.
    Akaleephan C; Wibulpolprasert S; Sakulbumrungsil R; Luangruangrong P; Jitraknathee A; Aeksaengsri A; Udomaksorn S; Tangcharoensathien V; Tantivess S
    Health Policy; 2009 Jul; 91(2):174-82. PubMed ID: 19150741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Access to essential medicines for children: a cross-sectional survey measuring medicine prices, availability and affordability in Hanam province, Vietnam.
    Dinh DX; Nguyen HTT; Nguyen VM
    BMJ Open; 2021 Aug; 11(8):e051465. PubMed ID: 34344685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Argentine health system: an analysis based on access to medicines].
    Marin GH
    Cien Saude Colet; 2021 Nov; 26(11):5453-5462. PubMed ID: 34852082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential medicines for children.
    Hoppu K; Sri Ranganathan S
    Arch Dis Child; 2015 Feb; 100 Suppl 1():S38-42. PubMed ID: 25613966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Judicialization of medicines: effectiveness of rights or break in public policies?
    Oliveira YMDC; Braga BSF; Farias AD; Pereira SPD; Ferreira MAF
    Rev Saude Publica; 2020; 54():130. PubMed ID: 33331524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Availability, price, and affordability of WHO priority maternal and child health medicine in public health facilities of Dessie, north-East Ethiopia.
    Hailu AD; Mohammed SA
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):221. PubMed ID: 32917201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What essential medicines for children are on the shelf?
    Robertson J; Forte G; Trapsida JM; Hill S
    Bull World Health Organ; 2009 Mar; 87(3):231-7. PubMed ID: 19377720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prices people pay for medicines in Zimbabwe.
    Gavaza P; Simoyi T; Makunike B; Maponga CC
    Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access to essential medicines in 195 countries: A human rights approach to sustainable development.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    Glob Public Health; 2019 Mar; 14(3):431-444. PubMed ID: 30187828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Right to health, essential medicines, and lawsuits for access to medicines--a scoping study.
    Vargas-Peláez CM; Rover MR; Leite SN; Rossi Buenaventura F; Farias MR
    Soc Sci Med; 2014 Nov; 121():48-55. PubMed ID: 25306409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
    Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
    Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How the Uruguayan Judiciary Shapes Access to High-Priced Medicines: A Critique through the Right to Health Lens.
    Pizzarossa LB; Perehudoff K; Forte JC
    Health Hum Rights; 2018 Jun; 20(1):93-105. PubMed ID: 30008555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
    BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
    Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.